Our government is a terrible thing — to hate (and a thank-you)
By
John O'Connor
Apr 17, 2015
Providers are finding their personal and professional relationships with the government tested these days. But before we all grab our torches and pitchforks, let’s take a deep breath.
Gentell releases latest wound advisor
Apr 14, 2015
Gentell Inc. announced its latest version of Gentell Wound Advisor, 3.15.1, has been released.
Loneliness in LTC: Overcoming disability, creating connections
By
Eleanor Feldman Barbera, Ph.D.
Apr 14, 2015
Reducing loneliness among facility residents has numerous benefits — for residents and staff. So why aren’t we doing better at it? Here’s what you need to know.
Naked crowd-funding — the salvation of long-term care
By
Gary Tetz
Apr 10, 2015
Crowdfunding isn’t the only way to raise money for a good cause, though it has recently netted one provider 60 televisions. Nudity is also an ever-attractive option.
Medela adds NPWT pumps
Apr 07, 2015
Medela announced the addition of the Invia® Motion™-15-Days and Invia®Motion™-Endure personal pumps to its Negative Pressure Wound Therapy line.
AHCA/NCAL joins Aging2.0
Apr 07, 2015
The American Health Care Association/National Center for Assisted Living has joined the Aging2.0 Alliance.
Wells Fargo Capital Finance announces deals
Apr 07, 2015
Wells Fargo Capital Finance announced that it acted as administrative agent on four deals totaling $140 million for healthcare companies.
Ventas to spin off SNF portfolio after hospital chain purchase
By
John Hall
Apr 07, 2015
Just a month after spending $2.9 billion to acquire medical office buildings and senior housing assets, Ventas announced Monday it will spin off its skilled nursing facility portfolio following the new...
How to do it… Resident security.
By
John Hall
Apr 06, 2015
All of the bells and whistles in the world won’t protect your staff and residents unless you spend the proper time and resources beforehand preparing for a new security system. Transitions from old...
FDA approves first biosimilar treatment
By
Elizabeth Newman
Apr 06, 2015
The Food and Drug Administration approved its first biosimilar product in March, opening the door for more costly drug alternatives.